Graves' disease presenting as hemiparkinsonism.
Davies
J S
JS
Department of Neurology, University Hospital of Wales, Heath Park, Cardiff, UK. DaviesJS@cf.ac.uk
Morrish
P K
PK
Scanlon
M F
MF
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D002231:Carbimazole / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006111:Graves Disease / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007453:Iodide Peroxidase / Q000276:immunology; D008297:Male; D020734:Parkinsonian Disorders; D011433:Propranolol / Q000627:therapeutic use; D011989:Receptors, Thyrotropin / Q000276:immunology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D001323:Autoantibodies; D011989:Receptors, Thyrotropin; D014284:Triiodothyronine; D002231:Carbimazole; D013972:Thyrotropin; D011433:Propranolol; D007453:Iodide Peroxidase; D013974:Thyroxine